Skip to content
Screener

Balchem BCPC Q4 2024 Annual earnings

Reported February 21, 2025 · Before market open

Revenue$240.0MMiss by $4.9M
EPS$1.03Miss by $0.08
Revenue estimate$244.9M
EPS estimate$1.11

Next report

Oct 20, 2026 (in a month)
Revenue estimate$289.2M
EPS estimate$1.54

Financials

Q4 2024

Income statement

See full
Revenue$240.0M+4.9%
Gross profit$86.3M+15.1%
Operating income$47.4M+23.8%
Net income$33.6M+26.0%
EPS (diluted)$1.03+25.6%

Balance sheet

See full
Cash & equivalents$49.5M-23.2%
Total debt$37.4M+0.1%
Total equity$1.1B+9.1%
Total assets$1.6B-1.4%

Cash flow

See full
Operating cash flow$52.3M-22.4%

Valuation & ratios

Valuation

as of 12/31/24
See full
Market cap$5.3B+10.4%
Enterprise value$5.29B+10.8%
P/E41.2×-3.0×
P/S5.6×+0.4×

Profitability

See full
Gross margin35.3%+2.5pp
Operating margin19.2%+1.9pp
Net margin13.5%+1.7pp

Returns & leverage

See full
Return on equity11.7%+0.8pp
Debt / equity0×0.0×
Current ratio2×-0.1×

Segments

By segment

See full
Human Nutrition and Health$147.3M+6.8%
Animal Nutrition and Health$58.3M+0.3%
Specialty Products$32.9M+6.0%

FAQ

When did Balchem report Q4 2024 earnings?
Balchem (BCPC) reported Q4 2024 earnings on February 21, 2025 before market open.
What were Balchem's Q4 2024 revenue and EPS?
Balchem reported revenue of $240.0M and eps of $1.03 for Q4 2024.
Did Balchem beat estimates in Q4 2024?
Revenue missed the consensus estimate of $244.9M by $4.9M. EPS missed the consensus estimate of $1.11 by $0.08.
Where can I find Balchem's Q4 2024 SEC filings?
You can read the 8-K earnings release (0001628280-25-006975) and the 10-K periodic report (0001628280-25-007202) directly on SEC EDGAR. The filing index links above go to sec.gov.